English | Español
Amanda Rupp | Aug 7, 2016

New initiative launched to decrease repeat heart attacks
Amanda Rupp | Aug 7, 2016

Joint financing supports Amylyx clinical trial for ALS treatment
Amanda Rupp | Aug 7, 2016

Coordinated care reduces treatment time for fatal heart attacks
Amanda Rupp | Aug 6, 2016

Adlyxin receives FDA approval as type 2 diabetes treatment
Amanda Rupp | Aug 6, 2016

New software created to facilitate developing drugs
Amanda Rupp | Aug 6, 2016

AbbVie launches venetoclax study for relapsed or refractory multiple myeloma
Amanda Rupp | Aug 6, 2016

Known regions of human cortex increase with Human Connectome Project
Amanda Rupp | Aug 6, 2016

NIH names new National Institute of Mental Health director

Trending
+ Pharmaceuticals
Patient Daily | Jun 10, 2025

Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+ Pharmaceuticals
Patient Daily | Jun 4, 2025

Doctor on compounded medications: They 'meet individual patient needs when commercial drugs are unsuitable'
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

Exon 20 Group questions effectiveness of 340B drug program